The Tumor Recall Response of Antitumor Immunity Primed by a Live, Recombinant Listeria monocytogenes Vaccine Comprises Multiple Effector Mechanisms

Chastellier, 1994, Fate of Listeria monocytogenes in murine macrophages: Evidence for simultaneous killing and survival of intracellular bacteria, Infect. Immun., 62, 543, 10.1128/IAI.62.2.543-553.1994 Tilney, 1989, Actin filaments and the growth, movement, and spread of the intracellular parasite, Listeria monocytogenes, J. Cell. Biol., 109, 1597, 10.1083/jcb.109.4.1597 Unanue, 1997, Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response, Immunol. Rev., 158, 11, 10.1111/j.1600-065X.1997.tb00988.x Ladel, 1996, Control of natural killer cell-mediated innate resistance against the intracellular pathogen Listeria monocytogenes by gamma/delta T lymphocytes, Infect. Immun., 64, 1744, 10.1128/IAI.64.5.1744-1749.1996 Skeen, 1995, Activation of gamma delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12, J. Immunol., 154, 5832, 10.4049/jimmunol.154.11.5832 Hiromatsu, 1992, A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice, J. Exp. Med., 175, 49, 10.1084/jem.175.1.49 Mombaerts, 1993, Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen, Nature, 365, 53, 10.1038/365053a0 Rogers, 1993, Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice, Infect. Immun., 61, 5090, 10.1128/IAI.61.12.5090-5096.1993 Czuprynski, 1994, Administration of antigranulocyte monoclonal antibody RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection, J. Immunol., 152, 1836, 10.4049/jimmunol.152.4.1836 Conlan, 1991, Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium, J. Exp. Med., 174, 741, 10.1084/jem.174.3.741 Czuprynski, 1990, Effects of purified anti-Lyt-2 mAb treatment on murine listeriosis: Comparative roles of Lyt-2+ and L3T4+ cells in resistance to primary and secondary injection, delayed-type hypersensitivity and adoptive transfer of resistance, Immunology, 71, 107 Mielke, 1988, T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: Superior role of Lyt-2+ cells in acquired immunity, Infect. Immun., 56, 1920, 10.1128/IAI.56.8.1920-1925.1988 Kagi, 1994, CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity, Eur. J. Immunol., 24, 3068, 10.1002/eji.1830241223 White, 1998, Perforin-deficient CD8+ T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-γ but requires TNF-α, J. Immunol., 160, 898, 10.4049/jimmunol.160.2.898 Mocci, 1997, The cytokine stew and innate resistance to L. monocytogenes, Immunol. Rev., 158, 107, 10.1111/j.1600-065X.1997.tb00996.x Tripp, 1993, Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist, Proc. Natl. Acad. Sci. USA, 90, 3725, 10.1073/pnas.90.8.3725 Emoto, 1995, Interleukin-4-producing CD4+NK1.1+ TCRα/βintermediate liver lymphocytes are down-regulated by Listeria monocytogenes, Eur. J. Immunol., 25, 3321, 10.1002/eji.1830251218 Flesch, 1997, IL-4 secretion by CD4+NK1+ T cells induces monocyte chemoattractant protein-1 in early Listeriosis, J. Immunol., 159, 7, 10.4049/jimmunol.159.1.7 Kauffmann, 1997, Interleukin-4 and listeriosis, Immunol. Rev., 158, 95, 10.1111/j.1600-065X.1997.tb00995.x Emoto, 1997, Transient control of interleukin-4 producing natural killer T cells in the livers of Listeria monocytogenes-infected mice by interleukin-12, Infect. Immun., 65, 5003, 10.1128/IAI.65.12.5003-5009.1997 Haak-Frendscho, 1992, Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection, J. Immunol., 148, 3978, 10.4049/jimmunol.148.12.3978 Schafer, 1992, Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine, J. Immunol., 149, 53, 10.4049/jimmunol.149.1.53 Pan, 1995, A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours, Nat. Med., 1, 471, 10.1038/nm0595-471 Pan, 1995, Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccine, Cancer Res., 55, 4776 Toes, 1999, CD4+ T cells and their role in antitumor immune responses, J. Exp. Med., 189, 753, 10.1084/jem.189.5.753 Greenberg, 1981, Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2− lymphocytes, J. Exp. Med., 154, 952, 10.1084/jem.154.3.952 Hung, 1998, The central role of CD4+ T cells in the antitumor immune response, J. Exp. Med., 188, 2357, 10.1084/jem.188.12.2357 Greenberg, 1986, Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: Cytolytic T cells can mediate eradication of disseminated leukemia, J. Immunol., 136, 1917, 10.4049/jimmunol.136.5.1917 Greenberg, 1985, Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+2− T cells. Tumor eradication does not require participation of cytotoxic T cells, J. Exp. Med., 161, 1122, 10.1084/jem.161.5.1122 Ossendorp, 1998, Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors, J. Exp. Med., 187, 693, 10.1084/jem.187.5.693 Ikonomidis, 1994, Delivery of a viral antigen to the class I processing and presentation pathway of Listeria monocytogenes, J. Exp. Med., 180, 2209, 10.1084/jem.180.6.2209 Frankel, 1995, Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector, J. Immunol., 155, 4775, 10.4049/jimmunol.155.10.4775 Yokoyama, 1991, Monoclonal antibody supernatant and ascites fluid production, 2.6.1 Corbett, 1975, Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure, Cancer Res., 35, 2434 Huang, 1994, Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens, Science, 264, 961, 10.1126/science.7513904 van Rooijen, 1994, Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications, J. Immunol. Methods, 174, 83, 10.1016/0022-1759(94)90012-4 van Rooijen, 1996, Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine, J. Immunol. Methods, 193, 93, 10.1016/0022-1759(96)00056-7 Tepper, 1992, An eosinophil dependent mechanism for the anti-tumor effect of IL-4, Science, 257, 548, 10.1126/science.1636093 Young, 1980, Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells, J. Immunol., 124, 199, 10.4049/jimmunol.124.1.199 Slifka, 2000, NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells, J. Immunol., 164, 2009, 10.4049/jimmunol.164.4.2009 Sokal, 1981 Nussenzweig, 1982, A monoclonal antibody specific for mouse dendritic cells, Proc. Natl. Acad. Sci. USA, 79, 161, 10.1073/pnas.79.1.161 Crowley, 1989, The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus, Cell. Immunol., 118, 108, 10.1016/0008-8749(89)90361-4 Pulendran, 1997, Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice, J. Immunol., 159, 2222, 10.4049/jimmunol.159.5.2222 Seljelid, 1999, Tumor stroma, Anticancer Res., 19, 4809 Mantovani, 1986, Origin and regulation of tumor associated macrophages: The role of tumor derived chemotactic factors, Biochim. Biophys. Acta, 865, 59 Arase, 1993, NK1.1+ CD4+ CD8− thymocytes with specific lymphokine secretion, Eur. J. Immunol., 23, 307, 10.1002/eji.1830230151 Cui, 1997, Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors, Science, 278, 1623, 10.1126/science.278.5343.1623 Nakamura, 1997, Involvement of NK1+ CD4− CD8− αβ T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice, J. Immunol., 158, 5338, 10.4049/jimmunol.158.11.5338 Takahashi, 1996, LPS induces NK1.1+ αβ T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells, J. Immunol., 156, 2436, 10.4049/jimmunol.156.7.2436 Takeda, 1996, Liver NK1.1+ CD4+ αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis, J. Immunol., 156, 3366, 10.4049/jimmunol.156.9.3366 Hsieh, 1993, Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages, Science, 260, 547, 10.1126/science.8097338 Seder, 1996, Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease, J. Immunol., 157, 2745, 10.4049/jimmunol.157.7.2745 Inge, 1992, Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor β1, Cancer Res., 52, 1386 Ranges, 1987, Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α, J. Exp. Med., 166, 991, 10.1084/jem.166.4.991 Tada, 1991, Transforming growth factor-β-induced inhibition of T cell function: Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state, J. Immunol., 146, 1077, 10.4049/jimmunol.146.3.1077 Weiskirch, 1994, Transforming growth factor-beta-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy, Cancer Immunol. Immunother., 38, 215, 10.1007/BF01533512 Hochrein, 2000, Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells, J. Exp. Med., 192, 823, 10.1084/jem.192.6.823 Schuler, 1999, T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice, J. Exp. Med., 189, 803, 10.1084/jem.189.5.803 Voest, 1995, Inhibition of angiogenesis in vivo by interleukin 12, J. Natl. Cancer Inst., 87, 581, 10.1093/jnci/87.8.581 Coughlin, 1998, Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis, J. Clin. Invest., 101, 1441, 10.1172/JCI1555